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American Foulbrood in South 
America with Essential Oils: 
Review
Sandra Rosa Fuselli, Pablo Gimenez Martinez, Giselle Fuentes, 
Rosa María Alonso-Salces and Matías Maggi
Abstract
American foulbrood (AFB) is the most severe bacterial disease that affects 
honey bees, having a nearly cosmopolitan distribution. AFB’s causative agent is 
Paenibacillus larvae. AFB kills infected honey bee larvae; however, it eventually 
leads to the collapse of the entire colony when left untreated. The infection takes 
place by the ingestion of the spores with the food provided by adult worker bees 
to the larvae. In South America (SA) the disease was first described in 1989 in 
Argentina, constituting the first sanitary challenge for beekeepers to overcome. 
Prevention and control measures of AFB in SA countries generally include vigilance 
for early diagnosis, isolation of apiaries with cases of AFB, and multiplication of 
healthy colonies with hygienic queens, among others. The extensive use of tetracy-
cline hydrochloride in Argentina has led to the development of resistant P. larvae 
isolates. In this context, the development of alternative and effective methods for 
the control and prevention of AFB disease is crucial. Currently, alternative strate-
gies for the prevention and treatment of AFB are being studied, mainly based on 
essential oils.
Keywords: Paenibacillus larvae, essential oils, quorum sensing, American foulbrood, 
Apis mellifera
1. Introduction
Along with wild bees, honeybees are the most important crop pollinators [1, 2]. 
Apis mellifera pollinates 77% of the plants responsible for producing food resources 
which sustain the global human population [1]. Since 1998, individual beekeepers 
have reported the unusual weakening and mortality of colonies, particularly in 
France, Belgium, Switzerland, Germany, the United Kingdom, the Netherlands, 
Italy, Spain, and North America [3, 4]. Most scientists agree that there is no single 
explanation for the extensive colony losses, but that interactions between different 
stressors are likely involved [5].
American foulbrood (AFB) is the most severe bacterial disease that affects 
honey bees, having a nearly cosmopolitan distribution (Figure 1) [6]. AFB only kills 
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infected honey bee larvae; however, it eventually leads to the collapse of the entire 
colony when left untreated. AFB is considered to be very contagious; therefore, it is 
a notifiable disease in most countries [7]. AFB’s causative agent is Paenibacillus lar-
vae, which is a flagellated gram-positive bacterium, whose main characteristic is the 
formation of highly resistant endospores. This pathogen affects the breeding during 
the larval or pupal stages [8]; its spores being the infectious form. Honey bee larvae 
are more susceptible to infection during the first 36 h after egg hatching [9], indeed 
only 10 spores are required to make a larva of less than 24 h old ill [10]. However, at 
later larval developmental stages, spore doses needed to successfully infect a larva 
are too high to occur under natural conditions [11]. The infection takes place by 
the ingestion of the spores with the food provided by adult worker bees (nurses) to 
the larvae [12]. The spores after germinating in the midgut of the larvae prolifer-
ate for several days. After this, P. larvae reaches the peritrophic matrix, penetrates 
the epidermal cells, produces septicemia causing death of the larva. Finally, dead 
larvae are digested by vegetative bacterial cells and converted to dry flakes contain-
ing millions of spores of P. larvae [12, 13]. The most evident symptoms of AFB are 
the irregular coating of the offspring, which show cells with cap and uncovered 
irregularly dispersed through the frames of the offspring; dark, sunken, and often 
perforated caps emitting a characteristic AFB odor; remnants of brown glue from 
the dead larvae forming a characteristic cord thread when removed with a wooden 
stick or an inlay; and a hard scale of larval residues at the bottom of the cell. The 
traditional diagnosis is made based on the observation of these clinical symptoms in 
the hive and in the microbial culture of material from infected colonies [14].
AFB was first described in South America (SA) in Argentina, in 1989, constitut-
ing the first sanitary challenge for beekeepers to overcome. It was hypothesized 
that the entrance of P. larvae, into the country was through bees imported from the 
USA [15]. AFB quickly spread to most important beekeeping centers of the country 
[16], with incidences as high as 30% in some geographic areas [17]. At least 30–45% 
of the colonies were lost due to AFB during those years (Eguaras, unpublished 
data). AFB was extended to Chile in 2002 and was controlled. New outbreaks were 
detected in 2005 in different regions [18] (Table 1).
In some countries the use of antibiotics, particularly tetracycline hydrochlo-
ride (OTC) [6, 12], is the most common method for prevention and treatment of 
Figure 1. 
Distribution of American foulbrood. (https://www.cabi.org/isc/datasheet/78183).
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infected colonies. However, in most European countries the use of antibiotics is 
banned, since their use is known to generate several problems including the pres-
ence of chemical residues in the beehive products (honey, pollen and wax), which 
eventually may even affect consumer health. Moreover, antibiotic application can 
affect life of bees and can increase the risk of occurrence of resistant strains [19]. To 
date, the presence of OTC resistant strains has been reported in Argentina, United 
States, Italy, New Zealand and United Kingdom [16, 20].
Prevention and control measures of AFB in SA countries generally include 
vigilance for early diagnosis, isolation of apiaries with cases of AFB, and multiplica-
tion of healthy colonies with hygienic queens, among others [21]. Brazilian, Chilean, 
and Uruguayan authorities specifically recommend the burning of colonies contain-
ing clinical signs of the disease in order to control the outbreaks [21]. The use of 
antibiotics in SA is not allowed, except in Argentina [18]. The extensive use of OTC 
in this country has led to the development of resistant P. larvae isolates [16], which is 
a major concern for Argentine beekeepers. In contrast, in Uruguay and Chile, where 
their use is not authorized, no resistant strains have been detected [22]. The endo-
spore resistance of P. larvae is an important problem in the control and prevention 
of AFB because these individuals can survive for more than 35 years in honey and/or 
beekeeping material and is resistant to high temperatures as well as to the most used 
disinfectants [10]. Most treatments are based on the use of broad spectrum antibi-
otics, which, in most cases, have been used continuously and excessively. In fact, 
different antibiotics, such as sulfathiazole and OTC, are able to inhibit the growth 
of P. larvae, but its use and abuse during the last years has led to the appearance of 
resistant strains and residues that contaminate the products of the hive. For these 
reasons, the use of antibiotics for the treatment and prevention of AFB is prohibited 
in several countries, and the affected colonies must be destroyed [23].
In this context, the development of alternative and effective methods for the 
control and prevention of AFB disease is crucial. These methods may consider the 
evidence of the bacteria-resistant phenomenon and meet the strict EU standards, as 
well as current trends in green consumption [24, 25]. Currently, alternative strate-
gies for the prevention and treatment of AFB are being studied, mainly based on 
essential oils [25–27], probiotics and propolis [28].
1.1 Essential oils
In light of developments in the scientific field, the medicinal properties of plants 
have received great interest due to their low toxicity, pharmacological activities 
Argentina Restricted distribution [15, 84]
Bolivia No information available [84]
Brazil Present [84]
Chile Present [84]
Colombia Disease never reported [84]
Ecuador Disease never reported [84]
French Guiana Disease never reported [84]
Peru Disease not reported [84]
Uruguay Present [84]
Venezuela Disease never reported [84]
Table 1. 
Distribution of P. larvae in South America.
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and economic viability [29]. These studies have focused on the benefits of phyto-
chemicals extracted from plants and their effect on human health. The additives 
naturally obtained from plants can be individual compounds, groups of compounds 
or essential oils (EOs). In recent times, there has been an increase in the interest 
of the food industry in natural compounds, either by direct addition or by its use 
in synergy with other compounds. It has been reported that the direct addition of 
essential oils and extracts of aromatic plants to food products exerts its antioxidant 
or antimicrobial effect [30].
Plants and other natural sources can provide a wide variety of complex and 
structurally diverse compounds. Plant extracts and essential oils have antifungal, 
antibacterial and antiviral properties and have been evaluated worldwide as poten-
tial sources of new antimicrobial compounds, agents that promote food preserva-
tion and alternatives to treat infectious diseases [31, 32]. It has been reported that 
essential oils possess significant antiseptic, antibacterial, antiviral, antioxidant, 
antiparasitic, antifungal, and insecticidal activities [33, 34]. Therefore, essential oils 
can serve as powerful tools to reduce bacterial resistance [33]. Oily aromatic liquids 
called essential oils (also called volatile oils) are obtained from plant materials 
(leaves, buds, fruits, flowers, herbs, branches, bark, wood, roots and seeds).
Being natural mixtures of very complex nature, the essential oils can consist 
of approximately 20–60 components at quite different concentrations. Essential 
oils are characterized by two or three main components that are present in fairly 
high concentrations (20–70%) compared to other components that are present 
in trace amounts. The amount of different components of essential oils varies 
between different parts of plants and different plant species since they are derived 
chemically from terpenes and their oxygenated derivatives, i.e., terpenoids which 
are esters of aromatic and aliphatic acid, and phenolic compounds. An important 
characteristic of essential oils and their components is their hydrophobicity, which 
allows them to interact with the lipids present in the cell membrane of bacteria and 
mitochondria, making them more permeable by altering their cellular structures. 
This eventually results in the death of bacterial cells due to the leakage of criti-
cal molecules and ions from the bacterial cell. Some compounds modulate drug 
resistance by targeting efflux mechanisms in several species of gram-negative 
bacteria [35]. An important function of essential oils in nature is the protection of 
plants by acting as antifungal, antibacterial, antiviral and insecticidal agents and 
also protection against herbivores by reducing the appetite of herbivores for plants 
with such properties. Health Services and Human Services Public Health Services 
have recognized essential oils as safe substances, and some of them contain 
compounds that can be used as antibacterial additives [33]. The efficacy of EOs has 
been reported in several studies against pathogens and food contaminants [36], 
suggesting their applications in the food industry [34, 37]. Several EOs have been 
evaluated for the in vitro and in vivo control of P. larvae (Table 2), as well as their 
acute oral toxicity to Apis mellifera (Table 3).
1.1.1 In vitro assays to control P. larvae
EOs from Achyrocline satureioides, Carum carvi, Cinnamomum spp., Cinnamomum 
zeylanicum, Citrus paradise, Cuminum cyminum, Cymbopogon citratus, Eucalyptus 
cinerea, Melaleuca alternifolia, Mentha piperita, Minthostachys verticillata, Origanum 
majorana, Origanum vulgare, Polygonum bistorta, Salvia officinalis, Salvia sclarea, 
Syzygium aromaticum, Tagetes minuta, Thymus vulgaris, Verbena, Pimenta dioica (L.) 
Merr., Litsea cubeba Pers., Trachyspermum ammi L., Mentha arvensis L., Mentha 
spicata L., Illicium verum Hook.f, Myristica fragrans Gronov., Cinnamomum camphora 
(L.) J. Presl., Ocimum tenuiflorum L., Daucus carota L., Zingiber officinale Rosc., and 
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Essential oil Technique Activity Amount 
tested
MICa MBCb References
Acantholippia seriphioides A. Gray Broth 
macrodilution
Inhibitory 236 mg/L [26]
Broth 
macrodilution
Inhibitory 300 mg/L [41]
Achyrocline satureioides Lam. Agar diffusion Inhibitory 10 μl [33]
Artemisia absinthium L. Broth 
microdilution
Inhibitory 416 mg/L 647 mg/L [42]
Artemisia annua L. Broth 
microdilution
Inhibitory 402 mg/L 624 mg/L [42]
Aloysia polystachia Griseb. Broth 
microdilution
Inhibitory 700–800 mg/L 900 mg/L [42]
Carapa guianensis Aubl. Broth 
microdilution
Inhibitory 25% (v/v) [27]
Carum carvi L. Agar diffusion Inhibitory 5, 10 μl [35]
Chamomilla recutita L. Agar diffusion Non-
inhibitory
5, 10 μl [35]
Cinnamomum aromaticum L. Agar diffusion Inhibitory 10 μl [34]
Agar diffusion Inhibitory 0.015% (v/v) (strong 
activity)
[34]
Cinnamomum camphora (L) J. Presl. Agar diffusion Inhibitory 10 μl [36]
Broth 
microdilution
Inhibitory 3200–0.78 286.2 ± 27.9 μg/ml 375.0 ± 34.8 [36]
Cinnamomum glandulifera Nees. Agar dilution Inhibitory 700 μg/ml [40]
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Essential oil Technique Activity Amount 
tested
MICa MBCb References
Cinnamomum zeylanicum L. Agar diffusion Inhibitory 2 mg/ml [36, 59]
Broth 
macrodilution
Inhibitory 58–83 μg/ml 108–112 μg/ml [42]
Inhibitory 25–100 mg/L 25–100 mg/L [45]
Inhibitory 38–50 μg/ml [46]
Inhibitory 25–67 μg/ml [6]
Cinnamomum zeylanicum + Thymus vulgaris L. Broth 
macrodilution
Inhibitory 66.6 μg/ml 95.83 μg/ml [42]
Citrus limon L. Broth 
microdilution
Inhibitory 764 mg/L 2293 mg/L [26]
Cinnamomum zeylanicum + Thymus vulgaris L. Broth 
macrodilution
Inhibitory 66.6 μg/ml 95.83 μg/ml [42]
Citrus limon L. Broth 
microdilution
Inhibitory 764 mg/L 2293 mg/L [42]
Citrus nobilis Lour Broth 
microdilution
Inhibitory 815 mg/L 2447 mg/L [42]
Citrus reticulata var. madurensis Blanco Agar diffusion Inhibitory 10 μl [34]
Agar dilution Inhibitory 0.12–1.0% (v/v) [34]
Copaifera officinalis L. Broth 
microdilution
Inhibitory 1.56% (v/v) [27]
Copaifera officinalis L. nanoemulsion Inhibitory 0.39% (v/v) [50]
Cymbopogon citratus + Thymus vulgaris L. Agar dilution Inhibitory 25–100 μg/ml [40]
C. citratus + T. vulgaris + Satureja hortensis L. + Origanum 
vulgare L. + Ocimum basilicum L.
Agar dilution Inhibitory 25–175 μg/ml [40]
C. citratus + T. vulgaris + O. basilicum Agar dilution Inhibitory 50–350 μg/ml [40]
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Essential oil Technique Activity Amount 
tested
MICa MBCb References
Cymbopogon martini Stapf. Broth 
microdilution
Inhibitory 1195 mg/L 1208 mg/L [42]
Cymbopogon nardus L. Broth 
microdilution
Inhibitory 319 mg/L 595 mg/L [42]
Daucus carota L. Agar diffusion Inhibitory 10 μl [36]
Broth 
microdilution
Inhibitory 3200–0.78 μg/
ml
412.8 ± 26.0 μg/ml 589.6 ± 48.2 μg/ml [36]
Eucalyptus cinerea F. Muell Agar diffusion Inhibitory 10 μl [33]
Eugenia spp. Agar diffusion Inhibitory [32]
Illicium verum Hook.f. Agar diffusion Inhibitory 10 μl [36]
Illicium verum Hook.f. Broth 
microdilution
Inhibitory 3200–0.78 278.6 ± 21.2 μg/ml 365.0 ± 32.1 [36]
Lavandula officinalis L. Broth 
macrodilution
Inhibitory 350–400 μg/ml [45]
Laurus nobilis L. Broth 
microdilution
Inhibitory 1000 μg/ml [39]
Broth 
microdilution
Inhibitory 12,879 μg/ml [36]
Lepechinia floribunda Benth. Broth 
microdilution
Inhibitory 394 mg/L 518 mg/L [26]
Lippia turbinata Griseb Broth 
macrodilution
Inhibitory 866 mg/L [26]
Litsea cubeba Pers. Agar diffusion Inhibitory 10 μl [36]
Litsea cubeba Pers. Broth 
microdilution
Inhibitory 3200–0.78 μg/
ml
85.0 ± 7.9 μg/ml 186.0 ± 21.2 μg/
ml
[36]
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Essential oil Technique Activity Amount 
tested
MICa MBCb References
Melaleuca alternifolia Maiden & Betche Agar diffusion Inhibitory 10 μl [34]
Agar dilution Inhibitory 0.015–0.12% (v/v) (strong 
activity)
[34]
Broth 
microdilution
Inhibitory 1095 mg/L 1187 mg/L [42]
Inhibitory 0.18–1.5% (v/v) [27]
Inhibitory 331 mg/L 585 mg/L [42]
Broth 
microdilution
Inhibitory 1000–1800 μg/ml 1600–2000 [81]
Mentha arvensis L. Broth 
microdilution
Inhibitory 144.7 ± 17.2 μg/ml 248.0 ± 23.4 μg/
ml
[36]
Mentha (hybrid) Broth 
microdilution
Inhibitory 600–700 μg/ml 1000–1200 μg/ml [81]
Mentha rotundifolia L. Broth 
microdilution
Inhibitory 600–1000 μg/ml 1600 ≥ 2000 μg/
ml
[81]
Mentha spicata L. Agar diffusion Inhibitory 10 μl [36]
Broth 
microdilution
Inhibitory 3200 to 
0.78 μg/ml
145.6 ± 15.4 μg/ml 256.0 ± 26.5 μg/
ml
[36]
Minthostachys mollis Kunth. Broth 
macrodilution
Inhibitory 775 mg/L [42]
Minthostachys verticillata Griseb Agar diffusion Inhibitory 10 μl [33]
Myristica fragrans Gronov. Agar diffusion Inhibitory 10 μl [36]
Myristica fragrans Gronov. Broth 
microdilution
Inhibitory 3200–0.78 285.8 ± 29.2 μg/ml 371.3 ± 29.0 [36]
Ocimum basilicum L. Agar dilution Inhibitory 350–450 μg/ml [40]
Inhibitory 0.06–0.12% (v/v) [34]
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Ocimum tenuiflorum L. Agar diffusion Inhibitory 10 μl [36]
Broth 
microdilution
Inhibitory 3200–0.78 412.8 ± 26.0 μg/ml 589.6 ± 48.2 [36]
Pimenta dioica (L.) Merr. Agar diffusion Inhibitory 10 μl [36]
Broth 
microdilution
Inhibitory 3200–0.78 μg/
ml
78.0 ± 8.2 μg/ml 162.0 ± 18.2 μg/
ml
[36]
Pimpinella anisum L. Agar diffusion Inhibitory 5 μl [35]
Inhibitory 10 μl [35]
Broth 
macrodilution
Inhibitory 300 μg/ml [46]
Salvia officinalis L. Agar diffusion Inhibitory 5 μl [35]
Inhibitory 10 μl [35]
Salvia sclarea L. Agar diffusion Inhibitory 10 μl [34]
Agar dilution Inhibitory 0.06% (v/v) (strong 
activity)
[34]
Satureja odora Griseb. Broth 
microdilution
Inhibitory 700–800 mg/L 900 mg/L [42]
Schinus molle L. Broth 
macrodilution
Inhibitory 666 mg/L [42]
Syzygium aromaticum L. Agar diffusion Inhibitory 10 μl [34]
Syzygium aromaticum L. Agar diffusion Inhibitory 5 μl [35]
Syzygium aromaticum L. Agar diffusion Inhibitory 10 μl [35]
Agar dilution Inhibitory 0.015% (v/v) (strong 
activity)
[34]
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Essential oil Technique Activity Amount 
tested
MICa MBCb References
Tagetes minuta Agar diffusion Inhibitory 10 μl [34]
Agar dilution Inhibitory 500–650 μg/ml [40]
Agar dilution Inhibitory 700–800 μl/L [48]
Broth 
macrodilution
Inhibitory 900–1000 mg/L [41]
Inhibitory 833 mg/L [42]
Thymol (component of Thymus vulgaris) Broth 
macrodilution
Inhibitory 100–133 μg/ml 133 μg/ml [26]
Trachyspermum ammi L. Agar diffusion Inhibitory 10 μl [36]
Broth 
macrodilution
Inhibitory 3200–0.78 μg/
ml
137.0 ± 12.2 μg/ml 224.8 ± 25.6 μg/ml [36]
Verbena officinalis L. Broth 
microdilution
Inhibitory 700–800 mg/L 850 mg/L [42]
Wedelia glauca Ortega Broth 
microdilution
Inhibitory 700–800 mg/L 950 mg/L [42]
Zingiber officinale Rosc. Agar diffusion Inhibitory 10 ml [36]
aMIC, Minimal Inhibitory Concentration.
bMBC, Minimal Bactericidal Concentration.
Table 2. 
Essential oils for the in vitro Paenibacillus larvae control.
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Essential oil Technique Toxicity Amount 
tested
References
Carapa guaianensis Spraying 
procedure
Non-toxic 25% (v/v) [27]
Carapa guaianensis 
nanoemulsion
Complete 
exposure
Non-toxic 10% (v/v) [50]
In-vivo against 
larva
Slightly toxic [50]
Copaifera officinalis Spraying 
procedure
Non-toxic 1.56% (v/v) [27]
Cymbopogon citratus Systemic 
administration
Moderately toxic 
(>2 μg EO/bee)
1, 2, 4, 8, 16 
and 32 μg EO/
bee
[47]
Cymbopogon 
citratus + Thymus 
vulgaris (20:80, v/v)
Systemic 
administration
Slightly toxic 
(24 h-LD50 = 15.94 μg 
b.e./bee)
0.19, 0.37, 
0.75, 1.50, 3.0 
and 6.0 μg 
b.e./bee
[47]
Cymbopogon 
citratus + Thymus 
vulgaris + Satureja 
hortensis + Origanum 
vulgare + Ocimum 
basilicum 
(5:11:21:26:37, 
v/v/v/v/v)
Systemic 
administration
Not determined 1.19, 2.37, 4.75, 
9.50, 19.0 and 
28.0 μg b.e./
bee
[47]
Cymbopogon 
citratus + Thymus 
vulgaris + Ocimum 
basilicum (10:20:70, 
v/v/v)
Systemic 
administration
Virtually non-toxic 
(24 h-LD50 = 122 μg 
b.e./bee)
0.625, 1.25, 
2.5, 5.0, 10.0 
and 20.0 μg 
b.e./bee
[47]
Cinnamomum 
zeylanicum
Systemic 
administration
Virtually non-toxic 2000, 4000, 
8000 and 
16,000 μg/ml
[46]
Eucalyptus globulus Complete 
exposure
Non-toxic 2.5, 5, 10 and 
20 ml per cage 
of EO
[44]
Eugenia spp. Systemic 
administration
Non-toxic 400 μg/ml [32]
Melaleuca alternifolia Spraying 
procedure
Toxic/non-toxic the 
nanoparticles of M. 
alternifolia
6.25% (w/v) [49]
Origanum vulgare Systemic 
administration
Moderately toxic (≥ 
3 μg EO/bee)
3, 6, 12, 24, 48 
and 96 μg EO/
bee
[47]
Rosmarinus officinalis Complete 
exposure
Non-toxic 2.5, 5, 10 and 
20 μl per cage 
of EO
[51]
Tagetes minuta Spraying 
procedure
Non-toxic 5% (w/v) [48]
Thymus vulgaris Systemic 
administration
Moderately toxic 
(>8 μg EO/bee)
2, 4, 8, 16, 32 
and 64 μg EO/
bee
[47]
Table 3. 
Essential oils toxicity assays on Apis mellifera.
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Pelargonium graveolens L., were able to inhibit the growth of P. larvae by the agar 
diffusion technique [38–45].
EOs from Cymbopogon citratus, Cinnamomum aromaticum, Citrus reticulata var. 
madurensis, Citrus paradisi, Heterothalamus alienus, Melaleuca alternifolia, Mentha 
piperita, Origanum majorana, Origanum vulgare, Salvia sclarea, Syzygium aromati-
cum, Tagetes minuta, Thymus vulgaris, as well as the mixtures of Cymbopogon citratus 
and Thymus vulgaris EOs (20:80, v/v), and Cymbopogon citratus, Thymus vulgaris, 
Satureja hortensis, Origanum vulgare, and Ocimum basilicum EOs (5:11:21:26:37, 
v/v/v/v/v) showed antibacterial activity against P. larvae [44, 46, 47].
EOs from Citrus sinensis, Cinnamomum spp., Eugenia spp., Thymus vulgaris, 
Verberna spp., Acantholippia seriphioides, Cinnamomum zeylanicum, Heterothalamus 
alienus Spreng., Pimpinella anisum, Foeniculum vulgare, and Eucalyptus globulosus, 
and the mixture of Thymus vulgaris EO, thymol and Cinnamomum zeylanicum EO 
(62.5:25:12.5, v/v/v) exhibited antibacterial activity against P. larvae by the broth 
macrodilution technique [40, 48–52].
1.1.2 Toxicity assays on Apis mellifera
Citrus sinensis, Cinnamomum spp., Cinnamomum zeylanicum, Cuminum cymi-
num, Eugenia spp., Thymus vulgaris, and Verbena spp. EOs were non-toxic for adult 
honey bees when they were fed with candy and the EO at different concentra-
tions by systemic administration [40, 53]. Cymbopogon citratus, Thymus vulgaris 
and Ocimum basilicum EOs, as well as Cymbopogon citratus and Thymus vulgaris 
EO mixture (50:50, v/v) were moderately toxic to adult honey bees. However, 
the Cymbopogon citratus, Thymus vulgaris and Coriandrum sativum EO mixture 
(33.3:33.3:33.3, v/v/v) presented negative mortality curves, meaning that there was 
less mortality at high doses. This fact disclosed that bees did not consume candy 
with high quantities of Coriandrum sativum EO [54]. When a solution containing 
a certain amount of EO was sprayed over a group of honey bees, Tagetes minuta, 
Carapa guianensis and Carapa officinalis EOs resulted to be non-toxic for adult bees 
[27, 55]; whereas Melaleuca alternifolia EO caused the death of the bees after 7 days 
of treatment. Nevertheless, the use of nanoparticles of Melaleuca alternifolia EO did 
not produce any toxic effect on honey bees [56]. Eucalyptus globosus and Rosmarinus 
officinalis EOs and the nanoemulsion of Carapa officinalis EO were not toxic for 
adult worker honey bees when they were completely exposed to the EO, that is, bees 
were in contact with the EO and ingested the EO [50, 57, 58]. The nanoemulsion 
of Carapa guianensis EO exhibited a toxic effect for larvae and adult honey bees, 
whereas the nanoemulsion of Carapa officinalis EO, a low toxic effect on larvae [57].
1.1.3 Mechanism of action of essential oils on P. larvae
Different mechanisms of action of EOs on bacteria have been reported, among 
others: degradation of the cell wall, affecting the cell morphology and damaging 
the cytoplasmic membrane; damage of membrane protein, disruption of cell wall, 
leading to leakage of the cell contents, reduction of proton motive force, reduc-
tion of intracellular ATP pool, via decreasing ATP synthesis; inhibition of quorum 
sensing and alteration of cell division [59]. The alteration of the membrane perme-
ability can be detected by the crystal violet assay [35] and the determination of 
the released UV-absorbing material assays [60]. The crystal violet assay is based 
on the fact that the compound enters easily when the cell membrane is defective. 
The released of UV-absorbing material assays is based on the fact that EOs can 
disrupt the cell membrane leading to a leakage of the cell content which is measured 
in the UV spectrum. The relationship between the chemical composition of EOs 
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and their antimicrobial mode of action against P. larvae has not been systemati-
cally researched so far. EOs are complex mixtures of low molecular weight volatile 
constituents biosynthesized by plants, which mainly include two biosyntheti-
cally related groups, i.e., terpenes and terpenoids, and aromatic and aliphatic 
constituents [61]. Most antimicrobial compounds are constitutively expressed 
by the plants, but others are synthesized as mechanism of defense in response to 
pathogens [59, 62]. Pellegrini et al. [62] demonstrated that the essential oils of 
Acantholippia seriphioides, Aloysia polystachia, Buddleja globosa, Lippia turbinata, 
Minthostachys mollis, Schinus molle and Solidago chilensis permeabilized and altered 
the cell membrane and the cytoplasmic membrane of P. larvae causing the leakage 
of cytoplasmic constituents.
1.1.4 Anti-quorum sensing and antimicrobial activity of essential oils
Antúnez et al. (2010) [70] determined that during the division P. larvae 
produces and secretes different proteins with proteolytic activity, such as metallo-
proteases and enolase, these proteins are secreted and remain on the surface of the 
spores, producing a response in the immune system of A. mellifera and are probably 
involved in the degradation of larval tissue.
In recent years, the detection of quorum sensing (QS) detection signals in bacte-
ria has added a new dimension to study the infection process. Through QS, bacteria 
depending on population density can activate specific genes [63–66]. The QS can 
regulate the expression of virulence factors, bioluminescence, sporulation, biofilm 
formation and conjugation [67–69]. Many bacteria coordinate the expression of 
multiple virulence factors, such as toxins, active redox compounds, siderophores, 
exoproteases, lipases and biofilm formation, thus maximizing the chances of infec-
tion and allowing better propagation [70, 71].
The QS signals occur while the bacterial population grows until it reaches a 
threshold concentration perceived by the bacteria and results in the activation 
or repression of specific genes. The accumulation of a stimulant amount of such 
molecules can occur only when a specific number of cells, known as a quorum, is 
present. These self-inducing molecules have been identified as acylated homoserine 
lactones in gram-negative and oligopeptide bacteria, thiolactone/lactone peptide, 
lanthionines, isoprenyl groups [65] and even acylated homoserine lactones in gram-
positive bacteria [72, 73]. Similar signaling mechanisms have not yet been dem-
onstrated in P. larvae. It is possible that larval infection by P. larvae is influenced 
by phenotypes regulated by QS, such as proteases exported by bacteria to their 
environment. The concept of QS has encouraged the development of a new non-
antibiotic antibacterial therapy through the use of QS inhibitor compounds [74, 75].
The increase in resistance to multiple drugs of the bacteria against traditional 
medicines drastically reduces the efficacy of conventional antibiotics. This multiple 
resistance is now recognized as a global problem [76]. Therefore, it is necessary to 
develop a new therapeutic strategy to prevent this type of multidrugging. A promis-
ing mechanism is to block cell-to-cell communication, establishing a strategy called 
quorum extinction [77]. Although traditional antimicrobial agents cause cell death 
of the pathogen, the use of systems that alter the QS sensors adopts a less aggressive 
strategy [78]. There are several sources of QS inhibitors (quorum quenchers), but 
so far the most diverse and abundant are derived from natural sources such as algae 
and plants. There are cases of QS inhibitors in bacteria, fungi, algae, bryozoans, 
corals, sponges [79], plant extracts [80], essential oils [42], compounds isolated 
from bacteria [81] and furanones, among others.
Essential oils extracted from plants, such as Cymbopogon citratus, Cymbopogon 
martini, Rosmarinus officinalis, Mentha piperita, Pelargonium odoratissimum and 
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Negundo vitex, and different products, such as citral, geraniol, thymol and the 
linalool, have been used to evaluate its protease inhibitory activity, constituting one 
of the virulence factors of bacteria that can be regulated by QS [82].
Pellegrini et al. [62] propose that the EO will act by inhibiting the production of 
proteases, inhibiting its transportation and secretion, inhibiting the detection of 
quorum or avoiding the loading of proteases. All extracellular bacterial proteases 
are synthesized as an inactive pre-proenzyme consisting of a signal peptide, a pro-
sequence and a maturity sequence. The peptide functions as a signal for the translo-
cation of the pre-proenzyme to the membrane. The pre-proenzyme is processed in 
the proenzyme by the peptidase signal. The accusation acts as a molecular chaper-
one that leads to a self-cleavage of the peptide bond that links the pro and mature 
sequences [83]. The EOs acted at some point in this regulatory mechanism. The 
inhibition of larval proteases by EO could be a form of therapeutic intervention; 
the blocking of bacterial virulence factors does not destroy or inhibit the growth of 
pathogenic bacteria. It is expected that this strategy will generate little pressure on 
the selection of bacteria and, therefore, could diminish the appearance of bacterial 
resistance and avoid the interruption of the microbiota of benefits in urticaria. In 
future investigations, it will be interesting to isolate and characterize automatically 
the potential autoinductors of P. larvae and study their relationship with prote-
ase regulation. EOs studies are promising to use EOs in hives with symptoms of 
Foulbrood for the control of damage caused by P. larvae.
2. Conclusion
The research carried out to study the in vitro and in vivo antimicrobial activ-
ity of essential oils against P. larvae, their toxicity in adult honey bees, as well 
as their mode of action (degradation of the cell wall, affecting cell morphology 
and damaging the cytoplasm membrane, coagulation of the cytoplasm, etc.) and 
anti-QS activity (inhibiting the production of proteases, inhibiting transporta-
tion and secretion of proteases, inhibiting the detection of quorum, etc.), has 
been thoroughly reviewed throughout this chapter. As far as honeybee larvae are 
the target of AFB disease, future research should focus on studying the effect of 
essential oils that are effective in vitro and non-toxic for adult honey bees on hon-
eybee larvae. In addition, more studies are still needed on the distribution and 
effects of these natural products in hives, adult honey bees, larvae, honey, royal 
jelly and other bee products to understand the pharmacokinetics and pharmaco-
dynamics within the hive. As well, research on the effectiveness of these natural 
antimicrobials in field conditions is imperative. Moreover, further studies should 
be conducted on the sporicidal properties of these natural substances to destroy 
spores of P. larvae for the prevention of AFB disease. And last but not least, the 
development of adequate delivery modes of the essential oils within the hives for 
in vivo treatment and prevention of the disease is another important issue that 
requires further research, to put these natural strategies into practice under true 
hive conditions.
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